CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.
Jin L, Tao H, Karachi A, Long Y, Hou AY, Na M, Dyson KA, Grippin AJ, Deleyrolle LP, Zhang W, Rajon DA, Wang QJ, Yang JC, Kresak JL, Sayour EJ, Rahman M, Bova FJ, Lin Z, Mitchell DA, Huang J.
Jin L, et al.
Nat Commun. 2019 Sep 5;10(1):4016. doi: 10.1038/s41467-019-11869-4.
Nat Commun. 2019.
PMID: 31488817
Free PMC article.